Margareta Reis

Summary

Affiliation: Lund University Hospital
Country: Sweden

Publications

  1. ncbi request reprint Therapeutic drug monitoring of racemic venlafaxine and its main metabolites in an everyday clinical setting
    Margareta Reis
    Department of Psychiatry, Linkoping University, Linkoping, Sweden
    Ther Drug Monit 24:545-53. 2002
  2. doi request reprint Serum concentrations of antidepressant drugs in a naturalistic setting: compilation based on a large therapeutic drug monitoring database
    Margareta Reis
    Department of Forensic Chemistry and Genetics, Swedish National Board of Forensic Medicine, Linkoping, Sweden
    Ther Drug Monit 31:42-56. 2009
  3. ncbi request reprint Inter- and intraindividual pharmacokinetic variations of mirtazapine and its N-demethyl metabolite in patients treated for major depressive disorder: a 6-month therapeutic drug monitoring study
    Margareta Reis
    Department of Medicine and Care, Division of Clinical Pharmacology, Linkoping University, Linkoping, Sweden
    Ther Drug Monit 27:469-77. 2005
  4. ncbi request reprint Therapeutic drug monitoring of racemic citalopram: a 5-year experience in Sweden, 1992-1997
    Margareta Reis
    Division of Psychiatry, Department of Neuroscience and Locomotion, Faculty of Health Sciences, Linkoping, Sweden
    Ther Drug Monit 25:183-91. 2003
  5. ncbi request reprint Serum disposition of sertraline, N-desmethylsertraline and paroxetine: a pharmacokinetic evaluation of repeated drug concentration measurements during 6 months of treatment for major depression
    Margareta Reis
    Department of Medicine and Care, Division of Clinical Pharmacology, Faculty of Health Sciences, Linkoping University, Linkoping, Sweden
    Hum Psychopharmacol 19:283-91. 2004
  6. ncbi request reprint Compliance with SSRI medication during 6 months of treatment for major depression: an evaluation by determination of repeated serum drug concentrations
    Margareta Reis
    Division of Clinical Pharmacology, Linkoping University, Linkoping, Sweden
    J Affect Disord 82:443-6. 2004
  7. ncbi request reprint Serum levels of citalopram and its main metabolites in adolescent patients treated in a naturalistic clinical setting
    Margareta Reis
    Division of Psychiatry, Department of Neuroscience and Locomotion, Faculty of Health Sciences, Linkoping University, Linkoping, Sweden
    J Clin Psychopharmacol 22:406-13. 2002
  8. ncbi request reprint Therapeutic drug monitoring of escitalopram in an outpatient setting
    Margareta Reis
    Department of Clinical Pharmacology, Faculty of Health Sciences, Linkoping University Hospital, Linkoping, Sweden
    Ther Drug Monit 29:758-66. 2007
  9. doi request reprint Therapeutic drug monitoring of ziprasidone in a clinical treatment setting
    Maria D Cherma
    Department of Clinical Pharmacology, Faculty of Health Sciences, Linkoping University Hospital, Sweden
    Ther Drug Monit 30:682-8. 2008
  10. ncbi request reprint Therapeutic drug monitoring data on olanzapine and its N-demethyl metabolite in the naturalistic clinical setting
    Elisabeth Skogh
    Division of Psychiatry, Department of Neuroscience and Locomotion, Faculty of Health Sciences, Linkoping University, Linkoping, Sweden
    Ther Drug Monit 24:518-26. 2002

Detail Information

Publications13

  1. ncbi request reprint Therapeutic drug monitoring of racemic venlafaxine and its main metabolites in an everyday clinical setting
    Margareta Reis
    Department of Psychiatry, Linkoping University, Linkoping, Sweden
    Ther Drug Monit 24:545-53. 2002
    ..A number of polycombinations of drugs were assessed for interaction screening, and a trend for lowered ODV/VEN ratio was found, predominantly with concomitant medication with CNS-active drug(s) known to inhibit CYP2D6...
  2. doi request reprint Serum concentrations of antidepressant drugs in a naturalistic setting: compilation based on a large therapeutic drug monitoring database
    Margareta Reis
    Department of Forensic Chemistry and Genetics, Swedish National Board of Forensic Medicine, Linkoping, Sweden
    Ther Drug Monit 31:42-56. 2009
    ..By presenting a comprehensive compilation of therapeutic drug monitoring data for each drug, a reference tool is created, in addition to improved pharmacokinetic knowledge of antidepressant drugs...
  3. ncbi request reprint Inter- and intraindividual pharmacokinetic variations of mirtazapine and its N-demethyl metabolite in patients treated for major depressive disorder: a 6-month therapeutic drug monitoring study
    Margareta Reis
    Department of Medicine and Care, Division of Clinical Pharmacology, Linkoping University, Linkoping, Sweden
    Ther Drug Monit 27:469-77. 2005
    ..To help clinicians improve their treatment of patients with major depressive disorder, the possible implications on the PK with a long-term treatment are important to study...
  4. ncbi request reprint Therapeutic drug monitoring of racemic citalopram: a 5-year experience in Sweden, 1992-1997
    Margareta Reis
    Division of Psychiatry, Department of Neuroscience and Locomotion, Faculty of Health Sciences, Linkoping, Sweden
    Ther Drug Monit 25:183-91. 2003
    ..Thus, this tendency of changes in the CIT disposition when multiple drugs are used (and multiple diseases are prevailing?) seems more general in character than specific for a certain drug or type of drugs...
  5. ncbi request reprint Serum disposition of sertraline, N-desmethylsertraline and paroxetine: a pharmacokinetic evaluation of repeated drug concentration measurements during 6 months of treatment for major depression
    Margareta Reis
    Department of Medicine and Care, Division of Clinical Pharmacology, Faculty of Health Sciences, Linkoping University, Linkoping, Sweden
    Hum Psychopharmacol 19:283-91. 2004
    ..For the future, continuous efforts are warranted to perform PK investigations in the natural clinical setting in which the drugs are usually prescribed...
  6. ncbi request reprint Compliance with SSRI medication during 6 months of treatment for major depression: an evaluation by determination of repeated serum drug concentrations
    Margareta Reis
    Division of Clinical Pharmacology, Linkoping University, Linkoping, Sweden
    J Affect Disord 82:443-6. 2004
    ..A recent estimation in a psychiatric cohort showed numbers of noncompliance between 10% and 60%. Therapeutic drug monitoring (TDM) is one method assessing compliance by analysis of drug concentration in the blood...
  7. ncbi request reprint Serum levels of citalopram and its main metabolites in adolescent patients treated in a naturalistic clinical setting
    Margareta Reis
    Division of Psychiatry, Department of Neuroscience and Locomotion, Faculty of Health Sciences, Linkoping University, Linkoping, Sweden
    J Clin Psychopharmacol 22:406-13. 2002
    ..64). In summary, the present study tentatively supports influences of sex, oral contraceptives, and smoking habits on the disposition of CIT in younger patients. Hence, future studies on CIT should assess these parameters...
  8. ncbi request reprint Therapeutic drug monitoring of escitalopram in an outpatient setting
    Margareta Reis
    Department of Clinical Pharmacology, Faculty of Health Sciences, Linkoping University Hospital, Linkoping, Sweden
    Ther Drug Monit 29:758-66. 2007
    ..However, women taking oral contraceptives showed a lower metabolic ratio compared with age-matched women. As a result of the wide range of the ratio in this population, these findings are not considered of clinical relevance...
  9. doi request reprint Therapeutic drug monitoring of ziprasidone in a clinical treatment setting
    Maria D Cherma
    Department of Clinical Pharmacology, Faculty of Health Sciences, Linkoping University Hospital, Sweden
    Ther Drug Monit 30:682-8. 2008
    ..In summary, great interindividual and intraindividual differences in ZIPconcentrations were observed. TDM of ZIP maybe used for individual dose adjustments and monitoring medication adherence...
  10. ncbi request reprint Therapeutic drug monitoring data on olanzapine and its N-demethyl metabolite in the naturalistic clinical setting
    Elisabeth Skogh
    Division of Psychiatry, Department of Neuroscience and Locomotion, Faculty of Health Sciences, Linkoping University, Linkoping, Sweden
    Ther Drug Monit 24:518-26. 2002
    ..The present TDM-based follow-up suggests that the influence of gender, smoking habits, and certain drug interactions may need to be considered for optimal dosage of OLA. TDM may be used for this purpose more readily in the future...
  11. doi request reprint Neonatal complications after maternal concomitant use of SSRI and other central nervous system active drugs during the second or third trimester of pregnancy
    Bengt Kallen
    Tornblad Institute, University of Lund, Lund, Sweden
    J Clin Psychopharmacol 32:608-14. 2012
    ..Polypharmacy with CNS-active drugs during the later part of the pregnancy seems to increase the occurrence of neonatal morbidity but difference in nature or strength of underlying psychiatric pathology may confound the findings...
  12. doi request reprint Maternal use of antipsychotics in early pregnancy and delivery outcome
    Margareta Reis
    Division of Clinical Pharmacology, Faculty of Health Sciences, Linkoping University, Linkoping, Sweden
    J Clin Psychopharmacol 28:279-88. 2008
    ..Because there seems to be little drug specificity, it is possible that underlying pathology or unidentified confounding explains the excess risk...
  13. ncbi request reprint [Stereochemistry and drug effects--a neglected field of knowledge]
    Margareta Reis
    Avdelningen för klinisk farmakologi, Hälsouniversitetet, Linkoping
    Lakartidningen 103:1305-6, 1309-11. 2006